• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经营母细胞瘤中的脑源性神经营养因子依赖性

BDNF dependence in neuroblastoma.

作者信息

Feng X, Jiang H, Baik J C, Edgar C, Eide F F

机构信息

Department of Neurology, University of Chicago, Chicago, Illinois, USA.

出版信息

J Neurosci Res. 2001 May 15;64(4):355-63. doi: 10.1002/jnr.1086.

DOI:10.1002/jnr.1086
PMID:11340642
Abstract

Neuroblastomas are heterogeneous tumors arising from sympathetic precursors in the neural crest. Growth factor stimulation of neuroblastomas promote diverse biological responses (mitogenesis, differentiation, cell death) depending on the particular tumor studied. Here we show that brief treatment with retinoic acid (RA) rendered the human neuroblastoma lines SY5Y, NGP, SMS-KCNR, and SK-N-SH dependent on brain-derived neurotrophic factor (BDNF) for survival. The BDNF- and trkB-expressing line SMS-KCN was dependent on an autocrine BDNF/trkB survival without exposure to RA. We conclude that the BDNF/trkB pathway plays an important role in neuroblastoma survival and speculate on a possible role in tumor pathogenesis.

摘要

神经母细胞瘤是起源于神经嵴交感神经前体细胞的异质性肿瘤。根据所研究的特定肿瘤,生长因子对神经母细胞瘤的刺激会引发多种生物学反应(有丝分裂、分化、细胞死亡)。在此,我们表明,用视黄酸(RA)进行短暂处理后,人神经母细胞瘤细胞系SY5Y、NGP、SMS-KCNR和SK-N-SH的存活依赖于脑源性神经营养因子(BDNF)。表达BDNF和trkB的细胞系SMS-KCN在未暴露于RA的情况下依赖自分泌BDNF/trkB存活。我们得出结论,BDNF/trkB信号通路在神经母细胞瘤存活中起重要作用,并推测其在肿瘤发病机制中可能发挥的作用。

相似文献

1
BDNF dependence in neuroblastoma.神经营母细胞瘤中的脑源性神经营养因子依赖性
J Neurosci Res. 2001 May 15;64(4):355-63. doi: 10.1002/jnr.1086.
2
[Effects of tyrosine kinase receptor B and brain-derived neurotrophic factor on chemoresistance in neuroblastoma].酪氨酸激酶受体B和脑源性神经营养因子对神经母细胞瘤化疗耐药性的影响
Zhonghua Er Ke Za Zhi. 2006 Jul;44(7):535-9.
3
Brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from chemotherapy-induced apoptosis via phosphatidylinositol 3'-kinase pathway.脑源性神经营养因子激活TrkB通过磷脂酰肌醇3'-激酶途径保护神经母细胞瘤细胞免受化疗诱导的凋亡。
Cancer Res. 2002 Nov 15;62(22):6756-63.
4
Resistance to chemotherapy mediated by TrkB in neuroblastomas.神经营母细胞瘤中TrkB介导的化疗耐药性。
Cancer Res. 2002 Nov 15;62(22):6462-6.
5
Nicotine regulates SH-SY5Y neuroblastoma cell proliferation through the release of brain-derived neurotrophic factor.尼古丁通过释放脑源性神经营养因子来调节SH-SY5Y神经母细胞瘤细胞的增殖。
Brain Res. 2006 Jul 26;1101(1):36-42. doi: 10.1016/j.brainres.2006.05.023. Epub 2006 Jun 21.
6
Genetic and pharmacologic identification of Akt as a mediator of brain-derived neurotrophic factor/TrkB rescue of neuroblastoma cells from chemotherapy-induced cell death.将Akt鉴定为脑源性神经营养因子/TrkB使神经母细胞瘤细胞从化疗诱导的细胞死亡中获救的介质的遗传学和药理学研究
Cancer Res. 2005 Mar 15;65(6):2070-5. doi: 10.1158/0008-5472.CAN-04-3606.
7
Cisplatin-induced cytotoxicity is blocked by brain-derived neurotrophic factor activation of TrkB signal transduction path in neuroblastoma.顺铂诱导的细胞毒性在神经母细胞瘤中被脑源性神经营养因子激活TrkB信号转导通路所阻断。
Cancer Lett. 2003 Apr 10;193(1):109-14. doi: 10.1016/s0304-3835(02)00723-1.
8
Effect of CEP-751 (KT-6587) on neuroblastoma xenografts expressing TrkB.CEP-751(KT-6587)对表达TrkB的神经母细胞瘤异种移植瘤的作用。
Med Pediatr Oncol. 2001 Jan;36(1):181-4. doi: 10.1002/1096-911X(20010101)36:1<181::AID-MPO1043>3.0.CO;2-Q.
9
[Blocking TrkB-BDNF signal pathway decreases the livability of neuroblastoma cells].阻断TrkB-BDNF信号通路可降低神经母细胞瘤细胞的存活率
Zhongguo Dang Dai Er Ke Za Zhi. 2008 Feb;10(1):47-50.
10
Prognostic and biological role of neurotrophin-receptor TrkA and TrkB in neuroblastoma.神经营养因子受体TrkA和TrkB在神经母细胞瘤中的预后及生物学作用
Klin Padiatr. 2000 Jul-Aug;212(4):200-5. doi: 10.1055/s-2000-9677.

引用本文的文献

1
Serum brain-derived neurotrophic factor (BDNF) as predictors of childhood neuroblastoma relapse.血清脑源性神经营养因子(BDNF)作为儿童神经母细胞瘤复发的预测因子。
BMC Cancer. 2023 Jul 17;23(1):670. doi: 10.1186/s12885-023-11159-9.
2
Long noncoding RNA DLX6-AS1 promotes neuroblastoma progression by regulating miR-107/BDNF pathway.长链非编码RNA DLX6-AS1通过调控miR-107/BDNF通路促进神经母细胞瘤进展。
Cancer Cell Int. 2019 Nov 27;19:313. doi: 10.1186/s12935-019-0968-x. eCollection 2019.
3
Combined cisplatin and aurora inhibitor treatment increase neuroblastoma cell death but surviving cells overproduce BDNF.
联合顺铂和 Aurora 抑制剂治疗可增加神经母细胞瘤细胞死亡,但存活细胞过度产生 BDNF。
Biol Open. 2016 Jul 15;5(7):899-907. doi: 10.1242/bio.016725.
4
Inhibition of BDNF in multiple myeloma blocks osteoclastogenesis via down-regulated stroma-derived RANKL expression both in vitro and in vivo.在体外和体内,多发性骨髓瘤中 BDNF 的抑制通过下调基质衍生的 RANKL 表达来阻断破骨细胞生成。
PLoS One. 2012;7(10):e46287. doi: 10.1371/journal.pone.0046287. Epub 2012 Oct 15.
5
Fine-tuning roles of endogenous brain-derived neurotrophic factor, TrkB and sortilin in colorectal cancer cell survival.微调内源性脑源性神经营养因子、TrkB 和分选酶在结直肠癌细胞存活中的作用。
PLoS One. 2011;6(9):e25097. doi: 10.1371/journal.pone.0025097. Epub 2011 Sep 26.
6
N-Myc down regulation induced differentiation, early cell cycle exit, and apoptosis in human malignant neuroblastoma cells having wild type or mutant p53.N-Myc下调可诱导具有野生型或突变型p53的人恶性神经母细胞瘤细胞发生分化、早期细胞周期退出及凋亡。
Biochem Pharmacol. 2009 Nov 1;78(9):1105-14. doi: 10.1016/j.bcp.2009.06.009. Epub 2009 Jun 18.
7
The effect of brain-derived neurotrophic factor on angiogenesis.脑源性神经营养因子对血管生成的影响。
J Huazhong Univ Sci Technolog Med Sci. 2009 Apr;29(2):139-43. doi: 10.1007/s11596-009-0201-6. Epub 2009 Apr 28.
8
Oligomeric amyloid decreases basal levels of brain-derived neurotrophic factor (BDNF) mRNA via specific downregulation of BDNF transcripts IV and V in differentiated human neuroblastoma cells.寡聚淀粉样蛋白通过特异性下调分化的人神经母细胞瘤细胞中脑源性神经营养因子(BDNF)转录本IV和V,降低BDNF mRNA的基础水平。
J Neurosci. 2007 Mar 7;27(10):2628-35. doi: 10.1523/JNEUROSCI.5053-06.2007.
9
Basic helix-loop-helix proteins bind to TrkB and p21(Cip1) promoters linking differentiation and cell cycle arrest in neuroblastoma cells.碱性螺旋-环-螺旋蛋白与TrkB和p21(Cip1)启动子结合,将神经母细胞瘤细胞中的分化与细胞周期停滞联系起来。
Mol Cell Biol. 2004 Apr;24(7):2662-72. doi: 10.1128/MCB.24.7.2662-2672.2004.